Article Details

BARD1 Life Sciences (ASX:BD1) enters trading halt to plan a capital raise

Retrieved on: 2021-07-21 05:26:15

Tags for this article:

Click the tags to see associated articles and topics

BARD1 Life Sciences (ASX:BD1) enters trading halt to plan a capital raise. View article details on hiswai:

Excerpt

BARD1 is a diagnostics company who's focussed on early detection of various cancers including breast, prostate, ovarian and pancreatic cancer. At this ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up